Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

SELL
$12.15 - $35.28 $93,761 - $272,255
-7,717 Closed
0 $0
Q4 2021

Feb 07, 2022

BUY
$30.49 - $48.49 $17,440 - $27,736
572 Added 8.01%
7,717 $263,000
Q3 2021

Nov 10, 2021

SELL
$41.66 - $52.52 $9,248 - $11,659
-222 Reduced 3.01%
7,145 $345,000
Q2 2021

Aug 04, 2021

BUY
$36.62 - $51.69 $10,143 - $14,318
277 Added 3.91%
7,367 $333,000
Q1 2021

May 10, 2021

BUY
$41.56 - $59.88 $2,368 - $3,413
57 Added 0.81%
7,090 $342,000
Q4 2020

Feb 08, 2021

SELL
$36.08 - $56.47 $15,911 - $24,903
-441 Reduced 5.9%
7,033 $379,000
Q3 2020

Nov 12, 2020

SELL
$33.26 - $40.48 $2,561 - $3,116
-77 Reduced 1.02%
7,474 $276,000
Q2 2020

Aug 11, 2020

SELL
$24.21 - $31.02 $9,877 - $12,656
-408 Reduced 5.13%
7,551 $234,000
Q1 2020

May 08, 2020

SELL
$20.5 - $34.53 $87,740 - $147,788
-4,280 Reduced 34.97%
7,959 $220,000
Q4 2019

Feb 11, 2020

SELL
$18.96 - $29.84 $6,636 - $10,444
-350 Reduced 2.78%
12,239 $358,000
Q3 2019

Nov 12, 2019

BUY
$19.12 - $26.24 $3,116 - $4,277
163 Added 1.31%
12,589 $241,000
Q2 2019

Jul 31, 2019

SELL
$19.57 - $24.1 $89,904 - $110,715
-4,594 Reduced 26.99%
12,426 $273,000
Q1 2019

May 06, 2019

SELL
$12.14 - $20.46 $5,535 - $9,329
-456 Reduced 2.61%
17,020 $348,000
Q4 2018

Feb 13, 2019

SELL
$11.24 - $18.5 $66,855 - $110,038
-5,948 Reduced 25.39%
17,476 $220,000
Q3 2018

Nov 13, 2018

BUY
$12.5 - $15.38 $10,562 - $12,996
845 Added 3.74%
23,424 $360,000
Q2 2018

Aug 03, 2018

SELL
$7.99 - $14.05 $34,181 - $60,105
-4,278 Reduced 15.93%
22,579 $296,000
Q1 2018

May 03, 2018

BUY
$7.23 - $8.76 $51,998 - $63,001
7,192 Added 36.57%
26,857 $219,000
Q4 2017

Feb 02, 2018

BUY
$8.02 - $11.18 $21,261 - $29,638
2,651 Added 15.58%
19,665 $174,000
Q3 2017

Nov 03, 2017

BUY
$9.11 - $11.26 $154,997 - $191,577
17,014
17,014 $189,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.16B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Wrapmanager Inc Portfolio

Follow Wrapmanager Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wrapmanager Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wrapmanager Inc with notifications on news.